Innovation in the biopharmaceutical industry is a closely monitored driver of positive public health and commercial outcomes. Despite high interest in tracking innovation as a measure of success, ther...
Read moreOryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announces the p...
Read moreUdL research questions use of 3-methyladenine in studies because of its toxicity
Read moreThe Biochemical Research Group of Oxidative Stress leads the project
Read moreEl cáncer de páncreas afecta mayoritariamente a personas de entre 65 y 70 años y es un tumor de difícil diagnóstico y una alta mortalidad.
Read moreInvestigadores desarrollan una metodología inédita que permite la producción de oligodendrocitos humanos (OLs) a partir de células madre pluripotentes
Read moreSOM Biotech announces its participation at the Drug Discovery Innovation Programme event 2020, being held virtually on November 17th. The conference will be chaired by Kevin McAllister, PhD, MBA Chief...
Read moreUn nuevo ensayo clínico de un compuesto que impide la proliferación celular en células cancerosas ha mostrado resultados prometedores en pacientes con tumores sólidos avanzados. Los resultados de ...
Read moreEuropean Biotechnology Life Science and Industry Magazine published the article “A pioneering real AI drug discovery technology” describing the approach of SOM Biotech.
Read moreEl Boletín Oficial del Estado ha publicado el Real Decreto 957/2020, de 3 de noviembre de 2020, por el que se regulan los estudios observacionales con medicamentos de uso humano. Este Real Decreto e...
Read moreOur latest article has just been published in the Journal of Medicinal Chemistry, describing some of the work carried out as part of our long-standing collaboration with Esteve Pharmaceuticals. The...
Read moreAre you developing a drug and need help with regulatory affairs?
Read more